BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06096116-completion@plaintrial.com
DTSTAMP:20261028T031147Z
DTSTART;VALUE=DATE:202803
SUMMARY:Phase 3 Study on the Efficacy and Safety of Human Plasma Derived An
 tithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo C
 ardiac Surgery Necessitating Cardiopulmonary Bypass — estimated completi
 on date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06096116
URL:https://plaintrial.com/trial/NCT06096116
END:VEVENT
END:VCALENDAR